MEDHIGH SIGNALOPERATIONAL10-K

Medifast has pivoted from GLP-1 transformation strategy to metabolic health focus while suffering massive profitability collapse despite revenue growth.

The company's dramatic shift from addressing GLP-1 competition to targeting broader metabolic health markets suggests previous transformation efforts failed. The 40% decline in active coaches (27,100 to 16,100) represents a fundamental breakdown in their core business model, as coaches are essential for revenue generation and customer acquisition.

Comparing 2026-02-17 vs 2025-02-18View on EDGAR →
FINANCIAL ANALYSIS

Revenue surged 244% to $935M, but this was more than offset by a massive profitability collapse with net income swinging from $2.1M profit to -$18.7M loss. Gross profit declined 38% and operating cash flow plummeted 72%, while inventory decreased 52% and receivables fell 59%, suggesting demand challenges. The financial picture reveals a company generating higher sales but at unsustainable margins with deteriorating cash generation capability.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-993%
$2.1M-$18.7M

Net income declined 993% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-593.8%
$2.9M-$14.2M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Revenue
P&L
+244.4%
$271.5M$934.8M

Strong top-line growth of 244.4% — accelerating demand or successful expansion into new markets.

Dividends Paid
Cash Flow
-72.7%
$715K$195K

Dividends cut 72.7% — significant signal of cash flow stress or capital reallocation priorities.

Operating Cash Flow
Cash Flow
-72%
$24.5M$6.9M

Operating cash flow fell 72% — earnings quality concerns; investigate working capital changes and non-cash items.

Accounts Receivable
Balance Sheet
-59.4%
$1.4M$584K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Inventory
Balance Sheet
-52.3%
$42.4M$20.2M

Inventory drawn down 52.3% — strong sell-through or deliberate destocking; watch for supply constraints.

Gross Profit
P&L
-38.1%
$444.6M$275.2M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

SG&A Expense
P&L
-34.5%
$441.7M$289.4M

SG&A reduced 34.5% — improved cost efficiency or headcount reduction improving operating margins.

Total Liabilities
Balance Sheet
-33.8%
$74.1M$49.1M

Liabilities reduced 33.8% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-02-17
PRIOR — 2025-02-18
ADDED
( Medifast, the Company, we or us ) is the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system.
As we enter 2026, the Company is moving from transformation to execution, leveraging its extensive experience in structured weight loss coupled with recent scientific research and enhanced product offerings to address the needs of a broader metabolic health market.
Medifast s approach focuses on addressing the root cause of metabolic dysfunction.
This strategic shift targets a larger and more sustainable market, focusing on a long-term growth strategy designed to guide the Company over the next decade by aligning science, products, and coaching with increasing demand for new solutions as awareness of metabolic dysfunction grows.
This growth strategy is fueled by improving coach productivity and expanding our coach network.
+7 more — sign up free →
REMOVED
( Medifast, the Company, we or us ) is the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTA VIA .
The Company is currently executing a comprehensive business transformation that will enable it to succeed in an environment that has been fundamentally impacted by rapid acceptance of GLP-1 weight loss medications.
We are a well-capitalized business with strong and effective leadership that has grown its lifestyle brand, OPTA VIA, into a significant health and wellness brand.
We have a powerful business model, building a network of approximately 27,100 active earning coaches and impacting more than 3 million lives.
Backed by more than 40 years of experience, clinically proven plans, innovative products, and a powerful integrated coach model, Medifast stands at the forefront of evidence-based wellness solutions.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →